THE EYES HAVE IT: This eye may have a lush lash, but it?s not because of pharmaceuticals. Image by GETTY IMAGES

NEWS ITEM: The Food and Drug Administration approved a new prescription drug that will grow longer, lusher lashes.

THE EYES HAVE IT: This eye may have a lush lash, but it?s not because of pharmaceuticals. Image by GETTY IMAGES

For gals who like their lashes long,
A brand new drug has come along.
It makes eyelashes flourish, grow
Beyond what is their status quo.

Forwarding the News

Thoughtful, balanced reporting from the Forward and around the web, bringing you updated news and analysis each day.

Terms(Required)

I agree to the Forward's Terms of Service and Privacy Policy

Email(Required)

Some women folk will think it cute
To have their lashes more hirsute.
At least that’s what researchers hope
As for new markets now they grope.

Mascara would be obsolete,
Unable, truly, to compete.

Some doctors, though, are not quite sure
About the drug’s alleged allure.
Will its effectiveness endure?
What ailment does it really cure?

Might daily users become vexed
By unintended side effects?
It’s aimed precisely at the lash,
But could it cause, say, a moustache?
(The hopes of women this would dash.
Just hear them cry “Alack! Alash!”)

They’d lash out at the FDA
Which gave the maker its OK,
And some would say it’s downright sin
To make cosmetic medicine.

The scientists appear perplexed
Which body part to target next.
The bushy eyebrow, black as coal,
Could be their new, upcoming goal.

If its new product fails and crashes,
The firm deserves a thousand lashes!

Far froyen kumt oyf der scene
A nye ploymdik meditsin.
Es mokht di vies horik voksn,
’Siz omshedlekh, nit kayn toxin.

Maydlekh glaykhn roykhik oygn,
Mener kumen, tsugetsoygn!
Azoy dertseylt di forshung shtark,
Bekoyekh, dortn vakst a mahrk.

Doktoyrim zaynen nit gevis
Di meditsin volt zayn like this.
Ken es tsubrengen dokh a krekhts?
Vos tut men vegn side effects?

Di vontses ken es gebn tsu
A maydl? Dos iz epes new!
M’ken nit yetst oyf zikher zayn
Oz ales vet geyn gut un fayn.

Di visinshaft iz felerdik,
Ganeyvish vi an oygnblik!
Der visnshoftler, dokh a kener,
Vert farblonzet (vi ale mener).

A roykhik brem ken zayn der tsil
Fun (kumendik) a shpeter pill.
Far dos, azoy, dos oyg’z bashert?
Vos iz di zokh? Vos iz der vert?

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

The coming year promises to be filled with more complex and historic developments. We are entering an era where independent, fact-based Jewish journalism will be more important than ever. We need to be ready for whatever 2025 will bring, and with your help, we can be.

We’ve set a goal to raise $260,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

—  Rachel Fishman Feddersen, Publisher and CEO

With your support, we’ll be ready for whatever 2025 brings.

$36 $500

$120 $180 Other amount